Étiquette : Media
-
Media Coverage: Advanced BioDesign Featured in Le Figaro: Accelerating Innovation Against Resistant Cancers
Advanced BioDesign is honored to be featured in Le Figaro Économie, which highlights our cutting-edge approach to overcoming cancer resistance through targeted inhibition of ALDH1—a key enzyme that enables tumor survival and relapse. Our lead compound, ABD-3001, currently in Phase 1 clinical trials for acute myeloid leukemia (AML), has shown promising biological activity even at…
Advanced BioDesign 